CVD-21: A novel instrument for predicting and monitoring cardiovascular disease

Researchers at Uppsala University have developed an instrument that makes it possible to measure 21 biomarkers for cardiovascular disease simultaneously with great precision by means of a simple blood test.

Merck finally has subcutaneous Keytruda results, and it’s going to regulators

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

November 20, 2024

Nutrition labels lead to healthier eating in teens, study finds

Study finds that middle and high school students in Texas who use nutrition labels tend to have healthier eating habits, highlighting the importance of nutrition

February 11, 2024

UK’s NICE recommends against coverage for AstraZeneca and Daiichi’s breast cancer drug Enhertu over cost-effectiveness

The UK’s National Institute for Health and Care Excellence (NICE) said Tuesday that it won’t recommend coverage of AstraZeneca and Daiichi Sankyo’s cancer drug Enhertu

March 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.